Drug Topics

APRIL 11, 2024

At AAP 2024, the Cardinal Health Pharmacy Transitions Services team hosted a session outlining how best to go about selling and buying a pharmacy.

201

201

Drug Store News

JANUARY 31, 2024

The transaction creates increased clinical and economic value for 11,500 specialty providers, including more than 7,000 physicians across 1,200 independent physician practices

111

111

Pharmacy Times

MARCH 8, 2024

Cardinal Health released its 2024 biosimilars report, including research and in-depth analyses on legislative development, payer landscapes, and new treatments in the pipeline.

129

129

Drug Topics

FEBRUARY 27, 2023

The new report reviewed the potential impact of biosimilars across multiple specialties.

98

98

Drug Store News

FEBRUARY 2, 2023

​​​​​​​Cardinal Health’s second quarter revenue increased 13% to $51.5 billion from the prior year period.

119

119

Drug Store News

FEBRUARY 24, 2023

The study reveals provider perceptions of commercially available biosimilars and anticipated launches, which have the potential to increase equitable access to critical treatments.

98

98

Drug Store News

MARCH 5, 2024

The study reveals the impact of a dramatic increase in commercially available biosimilars and progress in the areas of patient accessibility and treatment affordability.

64

64

Pharmacy Times

DECEMBER 19, 2023

Fran Gregory, PharmD, MBA, vice president of emerging therapies at Cardinal Health, discusses the dynamic landscape of the biosimilars market, providing key insights into its current status and future projections.

132

132

Drug Store News

AUGUST 15, 2023

Cardinal Health’s fourth quarter revenue increased 13% to $53.5 billion, while fiscal year 2023 revenues rose 13% to $205 billion.

97

97

Drug Store News

APRIL 19, 2023

Both facilities will support the company's medical segment, focusing on its U.S. medical products and distribution and at-Home Solutions businesses.

105

105

Pharmacy Times

OCTOBER 5, 2023

Naveen Mansukhani, BPharm, National Operations Director for Cardinal Health Retail Pharmacy Services, discussed how he is celebrating American Pharmacists Month.

132

132

Drug Store News

MAY 4, 2023

Cardinal Health’s revenue was $50.5 billion, an increase of 13% from the prior year period.

98

98

Drug Topics

DECEMBER 6, 2023

A Q&A with Lisa McCabe, PharmD, MBA, BSN, director of Health System Pharmacy at Cardinal Health.

Compounding 112

Compounding 112

Pharmacy Times

OCTOBER 9, 2023

Cheri Schmit, RPh, Senior Manager of clinical Solutions at Cardinal Health, discusses the role of the pharmacists, how the pharmacy profession has changed, and what is to come in the field.

132

132

Fierce Healthcare

FEBRUARY 6, 2024

Healthcare mergers and acquisitions are in no short supply as providers, health tech companies, retailers and other industry players look to expand their businesses and gain a competitive edge. Missouri's $10 billion health system merger, Cardinal Health's $1.2

106

106

Drug Store News

MARCH 9, 2023

The collaboration will initially focus on addressing interventions recommended for Medicare Advantage members of joint clients, but it may expand into additional services.

98

98

Pharmacy Times

DECEMBER 20, 2022

Michael Brown, vice president of Managed Services at Cardinal Health, discusses ways for pharmacists to help manage costs post-pandemic.

132

132

Drug Store News

JUNE 8, 2023

Cardinal Health's Outcomes business will combine with Transaction Data Systems to offer improved patient engagement and clinical pharmacy solutions.

105

105

Drug Store News

NOVEMBER 3, 2023

Cardinal Health’s first quarter revenue increased 10% to $54.8

52

52

Pharmacy Times

JULY 15, 2022

Debbie Weitzman of Cardinal Health, discussed how independent retail pharmacies quickly adjusted during the pandemic.

Independent Pharmacies 123

Independent Pharmacies 123

STAT

APRIL 22, 2024

Cardinal Health announced its pharmaceutical distribution contracts with UnitedHealth’s OptumRx unit will not be renewed after they expire at the end of June , Reuters notes. Evercore ISI analyst Elizabeth Anderson estimated the move will hurt Cardinal earnings per share in fiscal year 2025 by 45 cents to 50 cents.

Specialty Pharmacies 94

Specialty Pharmacies Insurance 94

Drug Topics

OCTOBER 2, 2022

Jordan Cardinal, EM/CC PharmD, a Medical Science Liaison in Integrated Diagnostic Solutions at BD, joins Drug Topics® to discuss the current outlook on the upcoming 2022-2023 flu season, and how the prevalence of the BA.5 5 variant of the SARS-CoV-2 virus might affect the health care outlook over the coming months.

98

98

Pharmacy Times

MAY 11, 2023

Josh Marsh, vice president and general manager of Sonexus Access and Patient Support at Cardinal Health, discussed how patient assistance programs are leveraging technology.

65

65

Pharmacy Times

MAY 15, 2023

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the role biosimilars are playing in the pharmaceutical market as well as in patient access.

65

65

Pharmacy Times

MAY 2, 2023

Fran Gregory, PharmD, MBA, vice president of Emerging Therapies at Cardinal Health, discussed the biosimilars landscape and where biosimilars fall in the process of pharmacy and medical benefit adoption.

65

65

PharmExec

JANUARY 18, 2024

Fran Gregory, VP of Emerging Therapies, Cardinal Health discusses her career, how both CAR-T therapies and personalization have been gaining momentum and what kind of progress we expect to see from them, some of the biggest hurdles facing their section of the industry, the importance of patient advocacy and so much more.

52

52

Pharmaceutical Commerce

JANUARY 22, 2024

A discussion of where cell and gene therapies are currently doing, what's on the horizon, personalization, and much more.

52

52

PioneerRx

DECEMBER 14, 2022

He was recently honored at the 2019 Cardinal Health RBC for winning the… Congratulations to Steve Sheldon of Sheldon’s Express Pharmacy in Bowling Green, KY!

52

52

Drug Store News

OCTOBER 23, 2022

Kroger Health and Cardinal Health are teaming up once more for Drug Take Back events slated for Saturday, Oct.

52

52

STAT

SEPTEMBER 9, 2022

Cardinal Health named Debbie Weitzman as chief executive officer of its pharmaceutical segment; Continue to STAT+ to read the full story…   Don’t be shy. Everyone wants to know who is coming and going. Editor’s note:  Our regular feature that focuses on a newly hired executive will return next week).

84

84

Drug Store News

JANUARY 27, 2023

The platform will combine and analyze datasets for live customer purchasing decisions.

52

52

STAT

MARCH 29, 2024

health insurers have agreed to start paying for the Wegovy weight-loss drug for certain people on Medicare with heart conditions, The Wall Street Journal reports. law and which many private health plans resisted covering due to cost. Well, whatever you do, have a grand time. But be safe. Enjoy, and see you soon.

Insurance Coverage 96

Insurance Coverage Insurance 96

Pharmaceutical Commerce

DECEMBER 19, 2022

Cardinal Health helps create a more predictable and efficient supply chain by investing in the future of cold-chain storage and transportation.

40

40

Pharmaceutical Commerce

DECEMBER 19, 2022

Cardinal Health helps create a more predictable and efficient supply chain by investing in the future of cold-chain storage and transportation.

40

40

pharmaphorum

JULY 6, 2022

A court in West Virginia has ruled that US drug distributors McKesson, AmerisourceBergen and Cardinal Health are not responsible for fuelling the opioid crisis that has claimed thousands of lives in the state. District court judge David Faber rejected a call by prosecutors to force the distributors to pay $2.5

Hospitals 59

Hospitals 59

STAT

OCTOBER 30, 2023

The eye drops are marketed by CVS Health, Rite Aid, and Cardinal Health, among others. The agency recommended against the use of 26 over-the-counter eye drop products mainly used to treat symptoms of dry eyes and provide relief against eye irritation.

FDA 85

FDA 85

PQA

SEPTEMBER 26, 2022

PQA has appointed 15 individuals from member organizations to serve on a technical expert panel (TEP) to review and provide input on draft specification for a health plan performance measure concept: COPD (chronic obstructive pulmonary disease) Treatment Ratio (CTR).

76

76